```html

Acute Otitis Media (AOM) – Comprehensive Guide

Overview

Acute otitis media (AOM) is a rapid‑onset infection of the middle ear space, located behind the eardrum. It is most common in young children but can affect people of any age. The condition usually follows a viral upper‑respiratory infection that leads to fluid buildup, bacterial overgrowth, and inflammation.

• Who it affects: Approximately 80% of cases occur in children younger than 5 years, with the highest incidence between 6–18 months. Adults account for ~20% of cases, often after a cold or sinus infection.
• Prevalence: In the United States, >5 million pediatric visits for AOM are recorded each year, making it one of the most common reasons for pediatric antibiotic prescriptions <sup>1</sup>. Worldwide, the WHO estimates ~7% of children under 5 experience at least one episode annually.

Symptoms

Symptoms can develop suddenly and may range from mild irritation to severe ear pain.

• Ear pain (otalgia): Often described as a sharp, throbbing pain that may worsen when lying down.
• Ear fullness or pressure: A sensation that the ear is “blocked.”
• Fever: Usually 38 °C (100.4 °F) or higher, more common in children.
• Irritability or crying (in infants): Particularly when lying on the affected side.
• Hearing loss: Temporary conductive loss due to fluid behind the eardrum.
• Ear drainage (otorrhea): Purulent fluid may leak if the eardrum ruptures.
• Balance problems or dizziness: Less common, may occur if the inner ear is affected.
• Headache or facial pain: Can accompany the infection.
• Redness of the tympanic membrane (TM): Visible during otoscopic exam.

Causes and Risk Factors

Primary Causes

AOM typically follows a viral upper‑respiratory infection (e.g., rhinovirus, influenza, RSV) that causes inflammation and edema of the eustachian tube. This obstruction prevents normal drainage of secretions from the middle ear, creating an environment where bacteria can proliferate. Common bacterial agents include:

• Streptococcus pneumoniae
• Haemophilus influenzae (non‑typeable)
• Moraxella catarrhalis

Risk Factors

• Age: Children 6‑18 months have the most horizontal, shorter eustachian tubes.
• Day‑care attendance: Increases exposure to respiratory viruses.
• Second‑hand smoke exposure: Irritates the respiratory mucosa.
• Formula feeding (vs. breastfeeding): Lack of protective antibodies from breast milk.
• Upper‑respiratory infections: Colds, flu, sinusitis.
• Allergies or allergic rhinitis: Chronic inflammation of the nasopharynx.
• Congenital ear abnormalities or craniofacial syndromes: E.g., cleft palate.
• Recent use of a pacifier: Associated with higher AOM rates in infants.

Diagnosis

Diagnosis is primarily clinical, supported by otoscopic findings.

History and Physical Exam

• Ask about recent cold, fever, ear pain, hearing changes.
• Inspect the external ear for trauma or blockage.
• Perform a pneumatic otoscopy or handheld otoscope to visualize the tympanic membrane.

Otoscopic Signs of AOM

• Bulging, immobile TM.
• Reduced or absent light reflex.
• Loss of normal landmarks (cone of light, malleus).
• Yellow or cloudy fluid behind the TM.
• Possible perforation with drainage.

Additional Tests (when indicated)

• Tympanometry: Confirms middle‑ear effusion by measuring compliance.
• Acoustic reflex testing: Helps differentiate conductive vs. sensorineural loss.
• Culture of otorrhea: Rarely needed; reserved for chronic/recurrent cases or when antibiotic failure is suspected.
• Imaging (CT/MRI): Only if complications such as mastoiditis or intracranial spread are suspected.

Treatment Options

When to Observe vs. Treat

Guidelines (American Academy of Pediatrics, 2013) suggest a “watchful waiting” approach for children ≥6 months with mild symptoms and no high‑risk features. Immediate antibiotics are recommended for:

• Children <6 months (any presentation).
• Severe otalgia or fever ≥39 °C.
• Otorrhea indicating TM perforation.
• Immunocompromised patients.

Antibiotic Therapy

First‑line	Dose (age‑adjusted)	Duration
Amoxicillin 80‑90 mg/kg/day	125 mg/5 mL PO q12h (infants), 250‑500 mg PO q8h (children)	5–7 days (≤2 y), 7–10 days (>2 y)
High‑dose amoxicillin (90 mg/kg/day) if recent antibiotics	Same as above	Same

If the patient is allergic to penicillin, alternatives include cefdinir, cefuroxime, or a macrolide (azithromycin) – though macrolides have lower efficacy against S. pneumoniae.

Adjunctive Pain Management

• Acetaminophen (Tylenol): 10‑15 mg/kg every 4–6 h, max 5 days.
• Ibuprofen (Advil/Motiv): 5‑10 mg/kg every 6–8 h, not for children <6 months.
• Warm compresses over the affected ear may provide comfort.

Procedures

• Myringotomy with tympanostomy tube placement: Consider for recurrent AOM (≥3 episodes in 6 months or ≥4 in 12 months) or persistent middle‑ear effusion >3 months causing hearing loss.
• Aspiration of middle‑ear fluid: Rare, reserved for severe cases unresponsive to antibiotics.

Lifestyle & Supportive Care

• Maintain adequate hydration.
• Encourage frequent oral intake; breastfeeding if possible.
• Elevate the child’s head while resting to reduce pressure.

Living with Acute Otitis Media

Daily Management Tips

• Medication adherence: Complete the full antibiotic course even if symptoms improve.
• Pain monitoring: Give scheduled acetaminophen/ibuprofen; assess pain score every 4 h.
• Activity: Normal play is generally safe; avoid water exposure (e.g., swimming) until the TM has healed.
• Hearing considerations: Temporary loss may affect language development in toddlers – monitor speech milestones and discuss with a pediatrician if concerns arise.
• Follow‑up: Re‑examination 48–72 h after starting antibiotics or sooner if worsening.

Special Situations

• Infants: Watch for increased fussiness, poor feeding, or bulging TM on exam – these may indicate severe pain.
• Adults: Persistent ear fullness after 2 weeks warrants otologic referral.

Prevention

• Breastfeeding: Provides IgA antibodies that reduce respiratory infections.
• Vaccinations:
  • PCV13 (pneumococcal conjugate) – reduces S. pneumoniae AOM by ~20%.
  • Hib vaccine – lowers H. influenzae‑type b infections.
  • Annual influenza vaccine – reduces viral URIs that can precede AOM.
• Hand hygiene: Regular hand washing or sanitizer use for children and caregivers.
• Avoid exposure to tobacco smoke: Smoke irritates the eustachian tube.
• Limit pacifier use after 6 months: Reduces risk of recurrent AOM.
• Day‑care hygiene policies: Encourage sick‑child exclusion and regular cleaning of toys.

Complications

While most cases resolve without sequelae, untreated or recurrent AOM can lead to:

• Mastoiditis: Infection spreads to the mastoid bone, causing pain behind the ear, swelling, and fever.
• Chronic suppurative otitis media: Persistent drainage and perforation.
• Hearing loss: Temporary conductive loss; repeated episodes may affect language acquisition in young children.
• Facial nerve palsy: Rare, due to inflammation near the facial nerve canal.
• Intracranial complications: Meningitis, brain abscess, or lateral sinus thrombosis – exceedingly rare but life‑threatening.

When to Seek Emergency Care

---

1. American Academy of Pediatrics. “The Diagnosis and Management of Acute Otitis Media.” _Pediatrics_, 2013; 131(3):e964‑e999.

2. WHO. “World Health Organization–Estimates of the Global Burden of Disease for Otitis Media.” 2020.

3. Mayo Clinic. “Acute middle ear infection (acute otitis media).” Accessed March 2024.

4. CDC. “Pneumococcal Vaccination.” Updated 2023.

```